New cell sources for CAR-based immunotherapy

• المؤلفون الرئيسيون: Marzieh Mazinani (مؤلف), Fatemeh Rahbarizadeh (مؤلف)
• التنسيق: كتاب
• منشور في: BMC, 2023-05-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Abstract Chimeric antigen receptor (CAR) T cell therapy, in which a patient's own T lymphocytes are engineered to recognize and kill cancer cells, has achieved striking success in some hematological malignancies in preclinical and clinical trials, resulting in six FDA-approved CAR-T products cu...